Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease.

Mai M AbdelmoatyJatin MachhiPravin YeapuriFarah ShahjinVikas KumarKatherine E OlsonR Lee MosleyHoward E Gendelman

Published in: Clinical and translational medicine (2022)

This monocyte profile provides an "early" and unique biomarker strategy to track clinical immune-based interventions, but requiring validation in larger case studies.

Keyphrases

dendritic cells
endothelial cells
peripheral blood
physical activity
immune response